Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JP5273675B2 - Care product for ophthalmic lens and method for hydrophilizing resin base material - Google Patents
[go: Go Back, main page]

JP5273675B2 - Care product for ophthalmic lens and method for hydrophilizing resin base material - Google Patents

Care product for ophthalmic lens and method for hydrophilizing resin base material Download PDF

Info

Publication number
JP5273675B2
JP5273675B2 JP2009137937A JP2009137937A JP5273675B2 JP 5273675 B2 JP5273675 B2 JP 5273675B2 JP 2009137937 A JP2009137937 A JP 2009137937A JP 2009137937 A JP2009137937 A JP 2009137937A JP 5273675 B2 JP5273675 B2 JP 5273675B2
Authority
JP
Japan
Prior art keywords
acid
pha
coenzyme
lens
care product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2009137937A
Other languages
Japanese (ja)
Other versions
JP2010286513A (en
Inventor
辰登士 中嶋
ショピネ パトリシア
康臣 笹井
丈治 柘植
由規子 持山
俊 佐藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Menicon Co Ltd
Tokyo Institute of Technology NUC
Original Assignee
Menicon Co Ltd
Tokyo Institute of Technology NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menicon Co Ltd, Tokyo Institute of Technology NUC filed Critical Menicon Co Ltd
Priority to JP2009137937A priority Critical patent/JP5273675B2/en
Publication of JP2010286513A publication Critical patent/JP2010286513A/en
Application granted granted Critical
Publication of JP5273675B2 publication Critical patent/JP5273675B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Eyeglasses (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a method for hydrophilizing the surface of a hydrophobic resin base material, in particular, an eye lens, which utilizes a reaction with enzyme, and to provide a processing liquid for the hydrophilization, and a hydrophilized eye-lens. <P>SOLUTION: The present invention provides an eye-lens care supply containing a composite of hydroxycarboxylic acid and coenzyme, and polyhydroxy alkanoic acid (PHA) polymerase. The present invention also provides the method for hydrophilizing a resin base material. The method includes polymerizing a hydroxycarboxylic acid on the surface of the resin base material under the presence of coenzyme and polyhydroxy alkanoic acid (PHA) polymerase. The invention also provide the eye lens hydrophilized by this method. <P>COPYRIGHT: (C)2011,JPO&amp;INPIT

Description

本発明は、疎水性樹脂基材の表面親水化方法、その親水化のための処理液(特に、眼用レンズ用ケア用品)、及び親水化処理された眼用レンズに関する。   The present invention relates to a method for hydrophilizing a surface of a hydrophobic resin substrate, a treatment liquid for the hydrophilization (particularly, a care product for an ophthalmic lens), and an ophthalmic lens that has been hydrophilized.

微生物によって製造可能なバイオプラスチックとして3−ヒドロキシ酪酸重合体などが知られている(特許文献1〜4)。このバイオプラスチックは親水性であることがわかっている。   A 3-hydroxybutyric acid polymer or the like is known as a bioplastic that can be produced by microorganisms (Patent Documents 1 to 4). This bioplastic has been found to be hydrophilic.

特開平6-145311号公報Japanese Unexamined Patent Publication No. 6-14511 特開平5-276934号公報Japanese Patent Laid-Open No. 5-276934 特開平5-64592号公報JP-A-5-64592 国際公開 WO2006/025375International Publication WO2006 / 025375

酸素透過性ハードコンタクトレンズやシリコーンハイドロゲルレンズの一番の問題は、装用時の不快感、水濡れ性の悪さである。プラズマ処理等の化学的・物理的表面改質が行われているが、いずれもレンズ使用中の耐久性に問題があった。また、コンタクトレンズ表面へのコーティング技術として、人工合成物、天然物(セルロース、PVAなど)を点眼、塗布、補涙液で固着、1次表面吸着させて、表面の親水化を付与させるという技術も開発されているが、既にレンズ表面に涙液成分である脂質成分が付着している場合、レンズ材質との相互作用が弱められ、効果が低減すると言う問題があった。   The main problems with oxygen-permeable hard contact lenses and silicone hydrogel lenses are discomfort during wearing and poor wettability. Although chemical and physical surface modification such as plasma treatment has been performed, there was a problem with durability during lens use. In addition, as a coating technology on the surface of contact lenses, artificially synthesized products and natural products (cellulose, PVA, etc.) are fixed with eye drops, applied, and tear solution, and adsorbed to the primary surface to impart hydrophilicity to the surface. However, when a lipid component, which is a tear fluid component, has already adhered to the lens surface, there is a problem that the interaction with the lens material is weakened and the effect is reduced.

一方、微生物由来の酵素を利用すれば、3−ヒドロキシ酪酸などのモノマー化合物を樹脂基材表面で重合することが可能となることが期待される。この酵素反応は穏やかな条件で行うことができるので、眼用レンズなどの機能性を付与された樹脂基材表面の親水化処理に適することが予想される。   On the other hand, if an enzyme derived from a microorganism is used, it is expected that a monomer compound such as 3-hydroxybutyric acid can be polymerized on the surface of the resin substrate. Since this enzyme reaction can be carried out under mild conditions, it is expected to be suitable for the hydrophilic treatment of the resin substrate surface provided with functionality such as an ophthalmic lens.

そこで本発明の目的は、酵素反応を利用した疎水性樹脂基材、特に眼用レンズ、の表面親水化方法、その親水化のための処理液、及び親水化処理された眼用レンズを提供することである。   Accordingly, an object of the present invention is to provide a method for hydrophilizing a surface of a hydrophobic resin substrate using an enzyme reaction, particularly an ophthalmic lens, a treatment liquid for the hydrophilization, and an ophthalmic lens subjected to a hydrophilization treatment. That is.

即ち、本発明は以下のものを提供する。
[1]
ヒドロキシカルボン酸と補酵素との複合体、およびポリヒドロキシアルカン酸(PHA)重合酵素を含む眼用レンズ用ケア用品。
That is, the present invention provides the following.
[1]
A care product for an ophthalmic lens comprising a complex of a hydroxycarboxylic acid and a coenzyme and a polyhydroxyalkanoic acid (PHA) polymerizing enzyme.

[2]
該ヒドロキシカルボン酸と補酵素との複合体がヒドロキシアルカン酸と補酵素Aとの複合体である[1]の眼用レンズ用ケア用品。
[2]
[1] The ophthalmic lens care product, wherein the complex of hydroxycarboxylic acid and coenzyme is a complex of hydroxyalkanoic acid and coenzyme A.

[3]
補酵素およびポリヒドロキシアルカン酸(PHA)重合酵素の存在下、樹脂基材表面上でヒドロキシカルボン酸を重合することを特徴とする樹脂基材の親水化方法。
[3]
A method for hydrophilizing a resin base material, comprising polymerizing hydroxycarboxylic acid on the surface of the resin base material in the presence of a coenzyme and a polyhydroxyalkanoic acid (PHA) polymerizing enzyme.

[4]
前記補酵素と前記ヒドロキシカルボン酸とが複合体を形成している[3]の方法。
[5]
さらに多価アルコールの存在下、前記重合が行われる[3]又は[4]の方法。
[4]
The method according to [3], wherein the coenzyme and the hydroxycarboxylic acid form a complex.
[5]
Furthermore, the method according to [3] or [4], wherein the polymerization is performed in the presence of a polyhydric alcohol.

[6]
該樹脂基材が眼用レンズである[3]〜[5]のいずれかの方法。
[7]
[6]の方法により親水化された眼用レンズ。
[6]
The method according to any one of [3] to [5], wherein the resin substrate is an ophthalmic lens.
[7]
An ophthalmic lens made hydrophilic by the method of [6].

本発明によれば、酵素を利用した穏やかな反応条件で樹脂基材表面を親水化することができる。この親水化は樹脂基材表面にヒドロキシカルボン酸の重合体を成長させることによって達成される。   According to the present invention, the resin substrate surface can be hydrophilized under mild reaction conditions using an enzyme. This hydrophilization is achieved by growing a hydroxycarboxylic acid polymer on the surface of the resin substrate.

本発明の眼用レンズ用ケア用品を用いた場合では、親水化処理は、例えば、レンズの洗浄、保存のケアのプロセス(終日装用)において達成されるもので、1次吸着したモノマー成分(ヒドロキシカルボン酸)がポリヒドロキシアルカン酸(PHA)重合酵素及び補酵素(例えば、補酵素A(コエンザイムA))の働きでレンズ表面において重合し、ケア用品の成分の一部が停止反応として働き、全体としてレンズ表面に保湿成分(ポリヒドロキシカルボン酸)が吸着する。また、この親水化処理は反復処理が可能である。   In the case of using the ophthalmic lens care product of the present invention, the hydrophilization treatment is achieved, for example, in the lens cleaning and storage care process (for all-day wear). Carboxylic acid) is polymerized on the lens surface by the action of polyhydroxyalkanoic acid (PHA) polymerizing enzyme and coenzyme (for example, coenzyme A (coenzyme A)), and a part of the components of the care product works as a stop reaction. As a result, a moisturizing component (polyhydroxycarboxylic acid) is adsorbed on the lens surface. Moreover, this hydrophilic treatment can be repeated.

より例示的には、コンタクトレンズ(CL)ケア用品に添加したヒドロキシアルカン酸などをレンズに1次吸着させ、ポリヒドロキシアルカン酸(PHA)重合酵素及び補酵素(例えば、コエンザイムA)の働きにより樹脂基材、特にプラスチックレンズ表面で重合させて親水性のポリマー膜、皮膜を形成させることができる。重合したポリエステルは疎水面をレンズ側、親水面を水溶液側に成長し、全体としてレンズ表面の親水性を発現すると共に涙液中に含まれる脂質が吸着することを防ぐコーティングとしても機能する。更に、CLケア用品に含まれる成分、ポロキサマー成分のポリエチレングリコール(PEG)鎖等の高分子増粘剤が重合の停止反応として働き、結果としてポリエステル鎖末端にポロキサマー等のポリマーのグラフト化が促進され、親水性が増す。本発明によれば、生体・細胞内で起きている現象をCLケア用品を利用して実施し、CLの親水化を行うことができる。   More specifically, hydroxyalkanoic acid or the like added to a contact lens (CL) care product is primarily adsorbed on the lens, and a resin is produced by the action of polyhydroxyalkanoic acid (PHA) polymerizing enzyme and coenzyme (eg, coenzyme A). It is possible to form a hydrophilic polymer film or film by polymerizing on the surface of the substrate, particularly the plastic lens. The polymerized polyester grows with a hydrophobic surface on the lens side and a hydrophilic surface on the aqueous solution side, so that the entire surface exhibits hydrophilicity on the lens surface and also functions as a coating that prevents the lipid contained in tears from adsorbing. Furthermore, polymer thickeners such as polyethylene glycol (PEG) chains of the components included in CL care products and poloxamer components act as a polymerization termination reaction, and as a result, grafting of polymers such as poloxamers on the polyester chain ends is promoted. , Increase hydrophilicity. According to the present invention, a phenomenon occurring in a living body / cell can be performed using a CL care product, and CL can be hydrophilized.

本発明の眼用レンズ用ケア用品によれば、例えば、眼用レンズを外し、そのレンズをケア用品で洗浄した後、ケースに入れてケア用品に浸漬した状態で保存し、翌日装用する一般的なケアシステムにおいて、レンズに付着した脂質は洗浄、特にこすり洗いにより容易に除去され、一晩保存液に浸漬している間にPHA重合体の付着によりレンズの親水化がなされ、翌朝には洗浄され且つ親水化されたレンズが装用できる。しかも、レンズに付着した重合体は涙液中に含まれる脂質が吸着することを防ぐコーティングとしても機能する。即ち、本発明によれば、レンズ装用→レンズを外して洗浄(脂質除去)→保存(この時点でPHA重合によりコーティング)→レンズ装用というサイクルで、毎日清潔で良好な装用感のレンズを使用できる。   According to the ophthalmic lens care product of the present invention, for example, the ophthalmic lens is removed, the lens is washed with the care product, stored in a case and immersed in the care product, and then worn for the next day. In a special care system, the lipid attached to the lens is easily removed by washing, especially by rubbing, and the lens is hydrophilized by the adhesion of the PHA polymer while immersed in a storage solution overnight, and then washed the next morning. And a hydrophilized lens can be worn. In addition, the polymer attached to the lens also functions as a coating that prevents the lipid contained in the tear fluid from adsorbing. That is, according to the present invention, a lens having a clean and good wearing feeling can be used every day in a cycle of lens wearing → lens removal and cleaning (lipid removal) → storage (coating by PHA polymerization at this point) → lens wearing. .

Nile Red観察の結果を示す図である。A:50 mM Tris-HCl (pH7.5)に浸漬(比較例1)、B:50 mM Tris-HCl (pH7.5)中でPHA重合(実施例1)。It is a figure which shows the result of Nile Red observation. A: Dipped in 50 mM Tris-HCl (pH 7.5) (Comparative Example 1), B: PHA polymerization in 50 mM Tris-HCl (pH 7.5) (Example 1). 原子間力顕微鏡(AFM)観察結果の内の高さ像を示す図である。図中、50 mM Tris-HClに浸漬(比較例1)とPHA重合(実施例1)とを比較する。It is a figure which shows the height image in an atomic force microscope (AFM) observation result. In the figure, immersion in 50 mM Tris-HCl (Comparative Example 1) and PHA polymerization (Example 1) are compared. AFM観察結果の内の位相像と誤差信号を示す図である。図中、50 mM Tris-HClに浸漬(比較例1)とPHA重合(実施例1)とを比較する。It is a figure which shows the phase image and error signal in the AFM observation result. In the figure, immersion in 50 mM Tris-HCl (Comparative Example 1) and PHA polymerization (Example 1) are compared. 実施例で使用したPHA重合酵素の調製方法を説明するための図である。It is a figure for demonstrating the preparation method of the PHA polymerase used in the Example. 実施例で使用したPHA重合酵素のアミノ酸配列(配列番号1)を示す図である。It is a figure which shows the amino acid sequence (sequence number 1) of PHA polymerase used in the Example.

本発明の一態様によれば、補酵素およびポリヒドロキシアルカン酸(PHA)重合酵素の存在下、樹脂基材表面上でヒドロキシカルボン酸を重合することを特徴とする樹脂基材の親水化方法が提供される。   According to one aspect of the present invention, there is provided a method for hydrophilizing a resin base material, comprising polymerizing hydroxycarboxylic acid on the surface of the resin base material in the presence of a coenzyme and a polyhydroxyalkanoic acid (PHA) polymerizing enzyme. Provided.

[ヒドロキシカルボン酸]
ヒドロキシカルボン酸は、分子内に少なくとも1つのヒドロキシル基と少なくとも1つのカルボキシル基を有する化合物であり、ポリヒドロキシアルカン酸(PHA)重合酵素によって重合可能であれば特に限定されない。これらヒドロキシル基とカルボキシル基との間で分子間エステル形成反応が起こり、ポリエステル重合体が形成される。
[Hydroxycarboxylic acid]
Hydroxycarboxylic acid is a compound having at least one hydroxyl group and at least one carboxyl group in the molecule, and is not particularly limited as long as it can be polymerized by a polyhydroxyalkanoic acid (PHA) polymerizing enzyme. An intermolecular ester forming reaction occurs between the hydroxyl group and the carboxyl group to form a polyester polymer.

ヒドロキシカルボン酸の例としては、ヒドロキシアルカン酸、フッ素、塩素、臭素、ヨウ素などのハロゲンで置換されたヒドロキシアルカン酸、ヒドロキシル基及びカルボキシル基含有芳香族化合物、ヒドロキシル基含有不飽和カルボン酸などが挙げられる。ヒドロキシカルボン酸の炭素数は3〜18であることが好ましく、3〜14であることがより好ましく、さらに本発明の親水性付与効果をより効果的に発現する上では、より短鎖の炭素数3〜8であることが好ましい。   Examples of hydroxycarboxylic acid include hydroxyalkanoic acid, hydroxyalkanoic acid substituted with halogen such as fluorine, chlorine, bromine, iodine, hydroxyl group- and carboxyl group-containing aromatic compound, hydroxyl group-containing unsaturated carboxylic acid, etc. It is done. The number of carbon atoms of the hydroxycarboxylic acid is preferably 3-18, more preferably 3-14, and in order to more effectively express the hydrophilicity-imparting effect of the present invention, the shorter chain carbon number. It is preferable that it is 3-8.

酵素下で反応が確認されているポリエステル形成用脂質成分として、以下の58種類のヒドロキシカルボン酸が挙げられる。
1 3-ヒドロキシプロピオン酸
2 3-ヒドロキシブタン酸
3 3-ヒドロキシペンタン酸
4 3-ヒドロキシヘキサン酸
5 3-ヒドロキシヘプタン酸
6 3-ヒドロキシオクタン酸
7 3-ヒドロキシノナン酸
8 3-ヒドロキシデカン酸
9 3-ヒドロキシ-4-シクロヘキシルブタン酸
10 3-ヒドロキシドデカン酸
11 3-ヒドロキシテトラドデカン酸
12 3-ヒドロキシ-2-ブタン酸
13 3-ヒドロキシ-4-ペンタン酸
14 3-ヒドロキシ-4-ヘキサン酸
15 3-ヒドロキシ-5-ヘキサン酸
16 3-ヒドロキシ-6-オクタン酸
17 3-ヒドロキシ-7-オクタン酸
18 3-ヒドロキシ-8-ノナン酸
19 3-ヒドロキシ-9-デカン酸
20 3-ヒドロキシ-5-ドデカン酸
21 3-ヒドロキシ-5-テトラデカン酸
22 3-ヒドロキシ-5,8-テトラデカン二酸
23 3-ヒドロキシ-2-メチルブタン酸
24 3-ヒドロキシ-2-メチルペンタン酸
25 3-ヒドロキシ-2,6-ジメチル-5-ヘプタン酸
26 3-ヒドロキシ-4-メチルヘキサン酸
27 3-ヒドロキシ-5-メチルヘキサン酸
28 3-ヒドロキシ-4-メチルオクタン酸
29 3-ヒドロキシ-5-メチルオクタン酸
30 3-ヒドロキシ-6-メチルオクタン酸
31 3-ヒドロキシ-7-メチルオクタン酸
32 3-ヒドロキシ-6-メチルノナン酸
33 3-ヒドロキシ-7-メチルノナン酸
34 3-ヒドロキシ-8-メチルノナン酸
35 3-ヒドロキシ-7-メチルデカン酸
36 3-ヒドロキシ-9-メチルデカン酸
37 3-ヒドロキシ-7-フルオロヘプタン酸
38 3-ヒドロキシ-9-フルオロノナン酸
39 3-ヒドロキシ-6-クロロヘキサン酸
40 3-ヒドロキシ-8-クロロオクタン酸
41 3-ヒドロキシ-6-臭化ヘキサン酸
42 3-ヒドロキシ-8-臭化オクタン酸
43 3-ヒドロキシ-11-臭化ウンデカン酸
44 7-シアノ-3-ヒドロキシヘプタン酸
45 9-シアノ-3-ヒドロキシノナン酸
46 3-ヒドロキシコハク酸メチルエステル
47 3-ヒドロキシアジピン酸メチルエステル
48 3-ヒドロキシコハク酸メチルエステル
49 3-ヒドロキシコハク酸エチルエステル
50 3-ヒドロキシピメリン酸プロピルエステル
51 3-ヒドロキシセバシン酸ベンジルエステル
52 4-ヒドロキシブタン酸
53 4-ヒドロキシペンタン酸
54 4-ヒドロキシヘキサン酸
55 5-ヒドロキシペンタン酸
56 3,12-ジヒドロキシドデカン酸
57 リンゴ酸
58 3-ヒドロキシ-5-フェニルペンタン酸

[補酵素およびポリヒドロキシアルカン酸(PHA)重合酵素]
ヒドロキシカルボン酸の重合触媒として本発明ではPHA重合酵素を使用する。PHA重合酵素は、水素細菌(Ralstonia eutropha)などの細菌由来ものを使用することができる。例えば、ポリ-3-ヒドロキシブタン酸重合酵素などが挙げられる。PHA重合酵素の具体例としては、図5のアミノ酸配列を有するものが挙げられる。当業者であれば容易に理解できるように、本発明で使用できるPHA重合酵素は図5のアミノ酸配列を有するものに限定されず、これには、図5のアミノ酸配列において1若しくは数個のアミノ酸が欠失、置換若しくは付加されたアミノ酸配列からなりかつPHA重合酵素活性を有するものも含まれる。
The following 58 types of hydroxycarboxylic acids are mentioned as the lipid component for forming a polyester whose reaction has been confirmed under an enzyme.
1 3-hydroxypropionic acid
2 3-hydroxybutanoic acid
3 3-Hydroxypentanoic acid
4 3-Hydroxyhexanoic acid
5 3-hydroxyheptanoic acid
6 3-hydroxyoctanoic acid
7 3-hydroxynonanoic acid
8 3-hydroxydecanoic acid
9 3-hydroxy-4-cyclohexylbutanoic acid
10 3-Hydroxydodecanoic acid
11 3-hydroxytetradodecanoic acid
12 3-hydroxy-2-butanoic acid
13 3-hydroxy-4-pentanoic acid
14 3-hydroxy-4-hexanoic acid
15 3-hydroxy-5-hexanoic acid
16 3-hydroxy-6-octanoic acid
17 3-hydroxy-7-octanoic acid
18 3-hydroxy-8-nonanoic acid
19 3-Hydroxy-9-decanoic acid
20 3-hydroxy-5-dodecanoic acid
21 3-Hydroxy-5-tetradecanoic acid
22 3-hydroxy-5,8-tetradecanedioic acid
23 3-hydroxy-2-methylbutanoic acid
24 3-hydroxy-2-methylpentanoic acid
25 3-hydroxy-2,6-dimethyl-5-heptanoic acid
26 3-Hydroxy-4-methylhexanoic acid
27 3-Hydroxy-5-methylhexanoic acid
28 3-Hydroxy-4-methyloctanoic acid
29 3-Hydroxy-5-methyloctanoic acid
30 3-hydroxy-6-methyloctanoic acid
31 3-hydroxy-7-methyloctanoic acid
32 3-hydroxy-6-methylnonanoic acid
33 3-hydroxy-7-methylnonanoic acid
34 3-Hydroxy-8-methylnonanoic acid
35 3-hydroxy-7-methyldecanoic acid
36 3-hydroxy-9-methyldecanoic acid
37 3-Hydroxy-7-fluoroheptanoic acid
38 3-hydroxy-9-fluorononanoic acid
39 3-Hydroxy-6-chlorohexanoic acid
40 3-hydroxy-8-chlorooctanoic acid
41 3-hydroxy-6-bromohexanoic acid
42 3-hydroxy-8-octanoic acid bromide
43 3-Hydroxy-11-brominated undecanoic acid
44 7-Cyano-3-hydroxyheptanoic acid
45 9-Cyano-3-hydroxynonanoic acid
46 3-Hydroxysuccinic acid methyl ester
47 3-Hydroxyadipic acid methyl ester
48 3-Hydroxysuccinic acid methyl ester
49 3-Hydroxysuccinic acid ethyl ester
50 3-Hydroxypimelic acid propyl ester
51 3-Hydroxysebacic acid benzyl ester
52 4-Hydroxybutanoic acid
53 4-Hydroxypentanoic acid
54 4-Hydroxyhexanoic acid
55 5-hydroxypentanoic acid
56 3,12-Dihydroxydodecanoic acid
57 Malic acid
58 3-Hydroxy-5-phenylpentanoic acid

[Coenzyme and polyhydroxyalkanoic acid (PHA) polymerization enzyme]
In the present invention, PHA polymerizing enzyme is used as a polymerization catalyst for hydroxycarboxylic acid. As the PHA polymerizing enzyme, those derived from bacteria such as hydrogen bacteria (Ralstonia eutropha) can be used. For example, poly-3-hydroxybutanoic acid polymerase is mentioned. Specific examples of the PHA polymerizing enzyme include those having the amino acid sequence of FIG. As can be easily understood by those skilled in the art, the PHA synthase that can be used in the present invention is not limited to the one having the amino acid sequence of FIG. 5, and includes one or several amino acids in the amino acid sequence of FIG. In which the amino acid sequence is deleted, substituted or added and has PHA polymerase activity.

本発明ではPHA重合酵素と共に補酵素を使用することが必要である。補酵素としては、補酵素A(コエンザイムA)などを挙げることができる。
補酵素はヒドロキシカルボン酸と複合体を形成していてもよく、この複合体の例としては、3-ヒドロキシブチリル補酵素Aが挙げられる。
In the present invention, it is necessary to use a coenzyme together with a PHA polymerizing enzyme. Examples of the coenzyme include coenzyme A (coenzyme A).
The coenzyme may form a complex with hydroxycarboxylic acid, and an example of this complex is 3-hydroxybutyryl coenzyme A.

[重合反応]
重合反応の概略をポリ-3-ヒドロキシブタン酸を例として以下の化学反応式で説明する。
[Polymerization reaction]
The outline of the polymerization reaction will be explained by the following chemical reaction formula using poly-3-hydroxybutanoic acid as an example.

上記化学反応式において、Rはメチル基であり、nはポリ-3-ヒドロキシブタン酸の重合度であり、(R)-3HA-CoAは3-ヒドロキシブタン酸と補酵素Aとの複合体(3-ヒドロキシブチリル補酵素A)であり、PhaCはポリ-3-ヒドロキシブタン酸重合酵素であり、CoA-SHは補酵素Aである。PHAの重合反応は、上図のように補酵素Aがアシル運搬体となってポリ-3-ヒドロキシブタン酸の重合度を増加させる。   In the above chemical reaction formula, R is a methyl group, n is the degree of polymerization of poly-3-hydroxybutanoic acid, and (R) -3HA-CoA is a complex of 3-hydroxybutanoic acid and coenzyme A ( 3-hydroxybutyryl coenzyme A), PhaC is poly-3-hydroxybutanoic acid polymerase, and CoA-SH is coenzyme A. The polymerization reaction of PHA increases the degree of polymerization of poly-3-hydroxybutanoic acid by using coenzyme A as an acyl carrier as shown above.

[樹脂基材]
本発明で親水化させる樹脂基材は、ヒドロキシカルボン酸の重合体が表面に物理的に付着或いは化学的に結合することによって、その表面の親水性が高まるものであれば特に制限されない。樹脂基材は、合成樹脂でも天然樹脂でもよく、また熱可塑性樹脂でも、熱硬化性樹脂でもよい。
[Resin substrate]
The resin base material to be hydrophilized in the present invention is not particularly limited as long as the hydroxycarboxylic acid polymer is physically attached or chemically bonded to the surface to increase the hydrophilicity of the surface. The resin base material may be a synthetic resin or a natural resin, and may be a thermoplastic resin or a thermosetting resin.

樹脂基材の具体例としては、医療機器用樹脂基材、特に眼用レンズ、などが挙げられる。眼用レンズの内でも装用時の不快感、水濡れ性の悪さが問題となっている酸素透過性ハードコンタクトレンズやシリコーンハイドロゲルレンズなどに特に本発明は有用である。   Specific examples of the resin substrate include a resin substrate for medical devices, particularly an ophthalmic lens. Among the ophthalmic lenses, the present invention is particularly useful for oxygen permeable hard contact lenses, silicone hydrogel lenses, and the like, which are problematic in wearing discomfort and poor water wettability.

[その他の成分]
本発明の親水化処理は、穏やかな反応条件で行うことが必要なので、緩衝剤の存在下で行うことが好ましい。緩衝剤としては、トリス塩酸緩衝液(Tris-HCl)、TE緩衝液、トリス緩衝生理食塩水などが挙げられる。
[Other ingredients]
Since the hydrophilic treatment of the present invention needs to be performed under mild reaction conditions, it is preferably performed in the presence of a buffer. Examples of the buffer include Tris-HCl buffer (Tris-HCl), TE buffer, Tris-buffered saline, and the like.

本発明の反応系には、眼用レンズ用ケア用品に含まれる成分、特に多価アルコール成分(ポロキサマー等の水酸基を含むノニオン性界面活性剤、PEG等の増粘剤、プロピレングリコール(PG)等の等張化剤等が挙げられる。)を存在させてもよい。このような成分の存在によって重合反応後により高い親水効果が得られる。   The reaction system of the present invention includes components contained in ophthalmic lens care products, particularly polyhydric alcohol components (nonionic surfactants containing hydroxyl groups such as poloxamer, thickeners such as PEG, propylene glycol (PG), etc. And an isotonic agent, etc.) may be present. Due to the presence of such components, a higher hydrophilic effect can be obtained after the polymerization reaction.

ポロキサマーは、ポリオキシエチレン(POE)n−ポリオキシプロピレン(POP)mブロックコポリマー系非イオン系界面活性剤であり、このn、mにより、分子量等を変化させた化合物が種々存在する。ポロキサマーの内でも、両末端がOH基のものが多価アルコールとなり、本発明の樹脂基材の親水化に寄与する。   Poloxamer is a polyoxyethylene (POE) n-polyoxypropylene (POP) m block copolymer nonionic surfactant, and there are various compounds whose molecular weight and the like are changed by n and m. Among the poloxamers, those having both OH groups at the both ends become polyhydric alcohols, which contribute to the hydrophilization of the resin substrate of the present invention.

[眼用レンズ用ケア用品]
本発明において眼用レンズ用ケア用品とは、日本コンタクトレンズ協会の定めたコンタクトレンズ用洗浄剤、保存剤、洗浄保存剤等に関する安全自主基準第2条に定められた各種ケア用品、即ちコンタクトレンズ用洗浄剤、保存剤、洗浄保存剤、溶解水を指すが、上記自主基準に示されている通り、用時調整用の顆粒、粉末、タブレット、ゲル等の形態をとっていてもよい。
[Care products for ophthalmic lenses]
In the present invention, the care product for ophthalmic lenses means various care products defined in Article 2 of the Voluntary Safety Standards concerning contact lens cleaning agents, preservatives, cleaning preservatives and the like defined by the Japan Contact Lens Association, that is, contact lenses This refers to cleaning agents, preservatives, cleaning preservatives, and dissolved water, but may be in the form of granules, powders, tablets, gels and the like for use adjustment as shown in the above voluntary standards.

本発明の眼用レンズ用ケア用品は、ヒドロキシカルボン酸と補酵素との複合体、およびポリヒドロキシアルカン酸(PHA)重合酵素を含む。眼用レンズ用ケア用品がCL洗浄液、CL保存液などの液状ケア用品である場合、ヒドロキシカルボン酸と補酵素との複合体の配合量は液状ケア用品中の濃度で10nM〜10mMであり、好ましくは100μM程度であり、ポリヒドロキシアルカン酸(PHA)重合酵素の配合量は液状ケア用品中の濃度で1pM〜10mMであり、好ましくは100nM程度である。眼用レンズケア用品が粉末、タブレット、フィルムなどの固体ケア用品である場合、固体ケア用品中のヒドロキシカルボン酸と補酵素との複合体、およびポリヒドロキシアルカン酸(PHA)重合酵素の配合量は、液体に溶解した際に濃度が液状ケア用品と同じになるような配合量である。   The ophthalmic lens care product of the present invention comprises a complex of a hydroxycarboxylic acid and a coenzyme, and a polyhydroxyalkanoic acid (PHA) polymerizing enzyme. When the ophthalmic lens care product is a liquid care product such as a CL cleaning solution or a CL preservation solution, the amount of the complex of hydroxycarboxylic acid and coenzyme is 10 nM to 10 mM in the liquid care product, preferably Is about 100 μM, and the compounding amount of polyhydroxyalkanoic acid (PHA) polymerizing enzyme is 1 pM to 10 mM, preferably about 100 nM, in the concentration in the liquid care product. When the ophthalmic lens care product is a solid care product such as a powder, tablet or film, the compounding amount of the hydroxycarboxylic acid and coenzyme complex and polyhydroxyalkanoic acid (PHA) polymerizing enzyme in the solid care product is The amount is such that when dissolved in a liquid, the concentration is the same as the liquid care product.

本発明の好適な眼用レンズケア用品を以下に例示する。
補酵素およびPHA重合酵素を含む眼用レンズ用ケア用品。
緩衝剤、補酵素およびPHA重合酵素を含む眼用レンズ用ケア用品。
Suitable ophthalmic lens care products of the present invention are exemplified below.
Care products for ophthalmic lenses containing coenzymes and PHA polymerizing enzymes.
Care product for ophthalmic lenses containing buffer, coenzyme and PHA polymerizing enzyme.

増粘剤、補酵素およびPHA重合酵素を含む眼用レンズ用ケア用品。
増粘剤、緩衝剤、補酵素およびPHA重合酵素を含む眼用レンズ用ケア用品。
Care product for ophthalmic lenses containing thickener, coenzyme and PHA polymerizing enzyme.
Care products for ophthalmic lenses containing thickeners, buffers, coenzymes and PHA polymerizing enzymes.

コンタクトレンズ表面の親水化
(試験試料)
トリス(トリメチルシロキシ)シリルスチレン55重量部、2,2,2−トリフルオロエチルメタクリレート35重量部、エチレングリコールジメタクリレート10重量部を混合し、ここへ重合開始剤として2,2’−アゾビス(2,4−ジメチルバレロニトリル)0.3重量部加え、よく撹拌して混合した。前記混合物をプラスチック製成形型(直径12 mm、深さ5 mm)に注入し、窒素雰囲気とされた循環式乾燥器中で、50℃で2時間予備重合を行ったのち、90℃へ昇温して30分間加熱保持し、重合を完結させた。
Hydrophilization of contact lens surface (test sample)
55 parts by weight of tris (trimethylsiloxy) silylstyrene, 35 parts by weight of 2,2,2-trifluoroethyl methacrylate, and 10 parts by weight of ethylene glycol dimethacrylate were mixed, and 2,2′-azobis (2 , 4-dimethylvaleronitrile) was added in an amount of 0.3 parts by weight, and the mixture was well stirred. The mixture is poured into a plastic mold (diameter 12 mm, depth 5 mm), preliminarily polymerized at 50 ° C for 2 hours in a circulation drier in a nitrogen atmosphere, and then heated to 90 ° C. Then, the mixture was kept heated for 30 minutes to complete the polymerization.

(前処理)
試験試料をコンタクトレンズ用洗浄・保存剤(O2ケアネオ(メニコン製))に一晩浸漬し、レンズ表面を洗浄した。翌日、洗浄液が残らないよう純水で丁寧に洗浄し、キムワイプで軽く水分を拭き取った後、実験に使用した。
(Preprocessing)
The test sample was immersed in a contact lens cleaning / preserving agent (O2 Care Neo (Menicon)) overnight to clean the lens surface. The next day, it was carefully washed with pure water so that no cleaning solution remained, and after wiping off the water with a Kimwipe, it was used for the experiment.

(試験方法および結果)
以下の記載において、反応溶液の濃度はすべて終濃度である。また、%表示は特に断らない限り重量%を意味する。結果を表1及び表2に示す。
(Test method and results)
In the following description, all concentrations of the reaction solution are final concentrations. Moreover, unless otherwise indicated,% display means weight%. The results are shown in Tables 1 and 2.

コントロール反応(比較例1〜4):
前処理後の試験試料を下記表1及び2に示される溶液にそれぞれ浸漬し、室温で一晩放置した。表面を純水で洗浄後、キムワイプで水分を吸い取った。このレンズ表面にH2Oを滴下、CCDカメラで撮影し静止接触角を測定した。一つのレンズ表面につき3回測定を行い、平均値を測定結果とした。
Control reaction (Comparative Examples 1-4):
The test samples after the pretreatment were immersed in the solutions shown in Tables 1 and 2 below and left overnight at room temperature. The surface was washed with pure water, and then moisture was absorbed with Kimwipe. H 2 O was dropped on the lens surface and photographed with a CCD camera, and the static contact angle was measured. The measurement was performed three times for each lens surface, and the average value was taken as the measurement result.

PHA重合反応:
(1) 重合酵素PhaCReと(R)-3HB-CoAを同時に添加する系(実施例1)
50 mM Tris-HClまたはO2ケアネオにレンズを浸漬し、そこに100 μM (R)-3-ヒドロキシブチリルCoA [(R)-3HB-CoA (モノマー)] と100 nM PhaCReを添加し、室温で一晩インキュベート(約16時間)することでPHA酵素重合反応を行った。比較例と同様に静止接触角を測定した。
PHA polymerization reaction:
(1) System in which polymerization enzymes PhaC Re and (R) -3HB-CoA are added simultaneously (Example 1)
Immerse the lens in 50 mM Tris-HCl or O2 care neo and add 100 μM (R) -3-hydroxybutyryl CoA [(R) -3HB-CoA (monomer)] and 100 nM PhaC Re to room temperature. The PHA enzyme polymerization reaction was performed by incubating overnight (about 16 hours). The static contact angle was measured as in the comparative example.

<PhaCReの調製方法>
Ralstonia eutropha由来のPHA重合酵素(PhaCRe)の発現および精製
pET15b::phaCReをE. coli BL21 (DE3)に導入した株(図4参照)を、100 μg/mLのアンピシリンを含むLB試験管培地中、37℃で15時間振とう前培養した。100 μg/mLのアンピシリンを含むLB培地(100 ml)に前培養液1 mLを加え、本培養を開始した。37℃で2時間振とう培養した後、終濃度が0.1 mMとなるようにisopropyl-β-D-thiogalactopyranoside (IPTG)を添加し、さらに30℃で4時間振とう培養を行なった。培養後、遠心分離により菌体を回収し-80℃で保存した。
<Preparation method of PhaC Re >
Expression and purification of PHA synthase (PhaC Re ) from Ralstonia eutropha
A strain in which pET15b :: phaC Re was introduced into E. coli BL21 (DE3) (see FIG. 4) was cultured in an LB test tube medium containing 100 μg / mL ampicillin at 37 ° C. for 15 hours with shaking. 1 mL of the preculture was added to LB medium (100 ml) containing 100 μg / mL ampicillin to initiate main culture. After shaking culture at 37 ° C. for 2 hours, isopropyl-β-D-thiogalactopyranoside (IPTG) was added to a final concentration of 0.1 mM, and further, shaking culture was performed at 30 ° C. for 4 hours. After cultivation, the cells were collected by centrifugation and stored at -80 ° C.

凍結した菌体を氷上で解凍した。解凍した菌体を20 mM イミダゾール、500 mM 塩化ナトリウム、5% グリセロール、0.05% 6-O-(N-Heptylcarbamoyl) methyl α-D-glucopyranoside(HECAMEG)を含む 20 mM リン酸ナトリウム緩衝液(pH 7.4)に懸濁した。懸濁後、フレンチプレスにより菌体細胞を破砕した(3回)。破砕後の粗酵素溶液を15000 gで30分間遠心分離した。上清を0.45 μmのセルロースアセテートフィルター(アドバンテック社)でろ過した。ろ液をアマシャムバイオサイエンス社製Ni Sepharose High Performance packed HiTrapTM column(5 mL)に注入した。AKTA explorer 10Sシステム(アマシャムバイオサイエンス社)を用いてイミダゾールの20〜500 mMの直線濃度勾配(100 ml)で溶出させた。流速は1 ml/minで行った。なお、精製は4℃を保ちながら行った。精製したサンプルは、エッペンに分注し、液体窒素で凍結させ-80℃で保存した。   The frozen cells were thawed on ice. The thawed bacterial body is 20 mM sodium phosphate buffer (pH 7.4) containing 20 mM imidazole, 500 mM sodium chloride, 5% glycerol, 0.05% 6-O- (N-Heptylcarbamoyl) methyl α-D-glucopyranoside (HECAMEG). ). After suspension, the cells were disrupted with a French press (3 times). The crude enzyme solution after crushing was centrifuged at 15000 g for 30 minutes. The supernatant was filtered through a 0.45 μm cellulose acetate filter (Advantech). The filtrate was injected into Ni Sepharose High Performance packed HiTrap ™ column (5 mL) manufactured by Amersham Bioscience. Using an AKTA explorer 10S system (Amersham Bioscience), elution was performed with a 20-500 mM linear concentration gradient (100 ml) of imidazole. The flow rate was 1 ml / min. The purification was performed while maintaining 4 ° C. The purified sample was dispensed into an eppen, frozen with liquid nitrogen and stored at -80 ° C.

得られた酵素のアミノ酸配列(配列番号1)を図5に示す。

(2) PhaCReと(R)-3HB-CoAを別々に添加する系(実施例5〜7)
50 mM Tris-HCl (pH7.5)に100 nM PhaCReを先に添加し、10〜30分室温でインキュベートした後、100 μM (R)-3HB-CoAを加えてPHAを重合。また、(R)-3HB-CoAを先に添加し10〜30分室温でインキュベートした後、PhaCReを加え、室温で一晩インキュベートすることでPHA酵素重合反応を行った。比較例と同様に静止接触角を測定した。
The amino acid sequence (SEQ ID NO: 1) of the obtained enzyme is shown in FIG.

(2) System in which PhaC Re and (R) -3HB-CoA are added separately (Examples 5 to 7)
First, 100 nM PhaC Re was added to 50 mM Tris-HCl (pH 7.5), incubated at room temperature for 10 to 30 minutes, and then 100 μM (R) -3HB-CoA was added to polymerize PHA. In addition, (R) -3HB-CoA was added first and incubated at room temperature for 10 to 30 minutes, and then PhaC Re was added and incubated overnight at room temperature to perform PHA enzyme polymerization reaction. The static contact angle was measured as in the comparative example.


(3) PEG200及びPx-PGの影響(実施例2〜4、8〜10)
(R)-3HB-CoA、PhaCRe、PEG200を同時に添加する系、PhaCReを先に添加した後、(R)-3HB-CoAおよびPEG200を添加する系、およびPHA重合後にPEG200を添加する系を行った。PHA重合後にPEG200を添加した系においては、50 mM Tris-HCl中に浸漬したレンズに100 nM PhaCReと100 μM (R)-3HB-CoAを同時に添加し室温で一晩インキュベートしPHAを重合した後、PEG200を添加した。ポリプロピレングリコールを含むPx-PG溶液についてもPEG200と同様に検討した。いずれの例も室温で一晩インキュベートすることでPHA酵素重合反応を行った。比較例と同様に静止接触角を測定した。PHA酵素重合反応後にPEG200、Px-PGを添加する場合、接触角の測定はPEG200、Px-PGを添加後、4時間後に行った。

(3) Influence of PEG200 and Px-PG (Examples 2 to 4, 8 to 10)
A system in which (R) -3HB-CoA, PhaC Re and PEG200 are added simultaneously, a system in which (R) -3HB-CoA and PEG200 are added after adding PhaC Re first, and a system in which PEG200 is added after PHA polymerization Went. In a system in which PEG200 was added after PHA polymerization, 100 nM PhaC Re and 100 μM (R) -3HB-CoA were simultaneously added to a lens immersed in 50 mM Tris-HCl, and incubated overnight at room temperature to polymerize PHA. Later, PEG200 was added. A Px-PG solution containing polypropylene glycol was also examined in the same manner as PEG200. In all cases, the PHA enzyme polymerization reaction was performed by incubating overnight at room temperature. The static contact angle was measured as in the comparative example. When PEG200 and Px-PG were added after the PHA enzyme polymerization reaction, the contact angle was measured 4 hours after the addition of PEG200 and Px-PG.

表1及び表2に示された実験結果から、本発明の親水化方法を行ったコンタクトレンズ表面は、その方法を行っていないコンタクトレンズ表面よりも水の接触角が低く、高い親水性を有していることがわかる。   From the experimental results shown in Table 1 and Table 2, the contact lens surface subjected to the hydrophilization method of the present invention has a lower water contact angle and higher hydrophilicity than the contact lens surface not subjected to the method. You can see that


(参考例)
PHA重合後の試験試料にNile Red(脂質やPHAに吸着する蛍光色素)を添加し、室温で30分インキュベートした後、紫外線照射下で観察を行った(図1)。その結果、Tis-HClに浸漬しただけの試料は蛍光を発しなかった(図1A)のに対して、PHA重合を行った試料の表面は蛍光を発した(図1B)ことから、試料表面にPHAのコーティングが形成されていることがわかった。

(Reference example)
Nile Red (a fluorescent dye that adsorbs to lipids and PHA) was added to the test sample after PHA polymerization, and the mixture was incubated at room temperature for 30 minutes and then observed under ultraviolet irradiation (FIG. 1). As a result, the sample just immersed in Tis-HCl did not emit fluorescence (FIG. 1A), whereas the surface of the sample subjected to PHA polymerization emitted fluorescence (FIG. 1B). It was found that a PHA coating was formed.

また、PHA重合後のレンズを原子間力顕微鏡(AFM)にて観察した(図2及び図3)。PHA重合前後の試験試料表面をAFMで観察した結果、明らかな差が見られた。試験試料自体の厚さが10 nm前後だとすると、それよりも高く見えている部分はPhaCReまたは重合されたPHAが吸着したものと考えられる。 Further, the lens after PHA polymerization was observed with an atomic force microscope (AFM) (FIGS. 2 and 3). When the surface of the test sample before and after PHA polymerization was observed with AFM, a clear difference was observed. Assuming that the thickness of the test sample itself is around 10 nm, PhaC Re or polymerized PHA is considered to be adsorbed in the portion that appears higher than that.

Claims (7)

ヒドロキシカルボン酸と補酵素との複合体、およびポリヒドロキシアルカン酸(PHA)重合酵素を含む眼用レンズ用ケア用品。   A care product for an ophthalmic lens comprising a complex of a hydroxycarboxylic acid and a coenzyme, and a polyhydroxyalkanoic acid (PHA) polymerizing enzyme. 該ヒドロキシカルボン酸と補酵素との複合体がヒドロキシアルカン酸と補酵素Aとの複合体である請求項1の眼用レンズ用ケア用品。   The ophthalmic lens care product according to claim 1, wherein the complex of hydroxycarboxylic acid and coenzyme is a complex of hydroxyalkanoic acid and coenzyme A. 補酵素およびポリヒドロキシアルカン酸(PHA)重合酵素の存在下、樹脂基材表面上でヒドロキシカルボン酸を重合することを特徴とする樹脂基材の親水化方法。   A method for hydrophilizing a resin base material, comprising polymerizing hydroxycarboxylic acid on the surface of the resin base material in the presence of a coenzyme and a polyhydroxyalkanoic acid (PHA) polymerizing enzyme. 前記補酵素と前記ヒドロキシカルボン酸とが複合体を形成している請求項3の方法。   The method of claim 3, wherein the coenzyme and the hydroxycarboxylic acid form a complex. さらに多価アルコールの存在下、前記重合が行われる請求項3又は4の方法。   The method according to claim 3 or 4, wherein the polymerization is carried out in the presence of a polyhydric alcohol. 該樹脂基材が眼用レンズである請求項3〜5のいずれかの方法。   The method according to claim 3, wherein the resin substrate is an ophthalmic lens. 請求項6の方法により親水化された眼用レンズ。   An ophthalmic lens hydrophilized by the method of claim 6.
JP2009137937A 2009-06-09 2009-06-09 Care product for ophthalmic lens and method for hydrophilizing resin base material Expired - Fee Related JP5273675B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009137937A JP5273675B2 (en) 2009-06-09 2009-06-09 Care product for ophthalmic lens and method for hydrophilizing resin base material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009137937A JP5273675B2 (en) 2009-06-09 2009-06-09 Care product for ophthalmic lens and method for hydrophilizing resin base material

Publications (2)

Publication Number Publication Date
JP2010286513A JP2010286513A (en) 2010-12-24
JP5273675B2 true JP5273675B2 (en) 2013-08-28

Family

ID=43542282

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009137937A Expired - Fee Related JP5273675B2 (en) 2009-06-09 2009-06-09 Care product for ophthalmic lens and method for hydrophilizing resin base material

Country Status (1)

Country Link
JP (1) JP5273675B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020251932A1 (en) * 2019-06-10 2020-12-17 Yield10 Bioscience, Inc. Transgenic land plants that express a polyhydroxyalkanoate synthase seed specifically with cytosolic localization

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH063501B2 (en) * 1985-09-24 1994-01-12 株式会社メニコン Agent for contact lenses
JP2933999B2 (en) * 1990-08-24 1999-08-16 トーメー産業株式会社 Method for making contact lenses hydrophilic
JPH0951793A (en) * 1995-06-09 1997-02-25 Nippon Oil & Fats Co Ltd Enzyme monomer, polymer and stain-removing agent for contact lens
US6440571B1 (en) * 1999-05-20 2002-08-27 Bausch & Lomb Incorporated Surface treatment of silicone medical devices with reactive hydrophilic polymers
JP2006163008A (en) * 2004-12-08 2006-06-22 Asahi Kasei Chemicals Corp Contact lens cleaner
JP2008245633A (en) * 2006-05-19 2008-10-16 Agri Bioindustry:Kk Recombinant coryneform bacterium and method for producing biodegradable polyester
JP2008111054A (en) * 2006-10-31 2008-05-15 Toray Ind Inc Transport storage container for contact lenses
JP4781398B2 (en) * 2008-06-03 2011-09-28 株式会社メニコンネクト Contact lens solution

Also Published As

Publication number Publication date
JP2010286513A (en) 2010-12-24

Similar Documents

Publication Publication Date Title
Bai et al. Antifogging/antibacterial coatings constructed by N-hydroxyethylacrylamide and quaternary ammonium-containing copolymers
CN101925451B (en) Methods of Coating Silicone Hydrogels
JP5473605B2 (en) Method for coating biomedical articles
AU2011276313B2 (en) Degradable superabsorbent polymers
JP5635998B2 (en) Package solution
US4687816A (en) Surface treatment of soft contact lenses
CN103827175A (en) Silicone hydrogel contact lenses
JP6930534B2 (en) Manufacturing method of medical device
JP2016133593A (en) Manufacturing method of contact lens
JP5609525B2 (en) Contact lens care formulation and packaging solution
CN105531604A (en) Hydrogel monomer mix containing added water
JP5273675B2 (en) Care product for ophthalmic lens and method for hydrophilizing resin base material
EP4441101A1 (en) Method for modifying polysaccharides by grafting polyetheramines, polysaccharides thus modified and preparations comprising same and having heat-sensitive rheological properties
JPH05269181A (en) Antibacterial resin molding and method for producing the same
BE1009403A3 (en) Flexible composition chloride polymer based vinyl, use thereof for the production of an article and article containing same.
JP5393488B2 (en) Manufacturing method of composite material
JP2003212940A (en) Polymer and ophthalmic lens using the same
Alemdar Oxygen-generating photocrosslinkable hydrogel
JP4024081B2 (en) Highly hydrous ophthalmic lens and method for producing the same
JP3572144B2 (en) Dextran ester copolymer
KR100214747B1 (en) Contact lens and method of producing a contact lens
Pemble The design, synthesis and characterisation of selected chitosan-based thin films and studies of their use as materials for antimicrobial, heavy metal adsorption, and wound dressing applications
JPH07218878A (en) Solvent for contact lens
Rondeau Synthesis and Application of Cellulose-Based Hydrogels for Anti-Biofouling in Marine Environments
JP5528228B2 (en) Cleaning / preserving solution for oxygen permeable hard contact lenses

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120313

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20120313

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20121205

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121207

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130220

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130409

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130508

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees